Quintrio
Home

WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES

Cosmos Holdings Inc. Common Stock

COSM

Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.

Last trade $2.80
Day change +$0.31 (+12.45%)
Day range $2.20 – $2.87
Volume 261,802
Market cap $13M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$12.53M
Price / earnings
—
Price / book
0.61×
Price / sales
0.17×
EV / sales
0.36×
EV / EBITDA
-1.6×

Profitability

Earnings per share
-$4.85
Return on assets
-39.68%
Return on equity
-117.98%
Dividend yield
0%

Liquidity and leverage

Debt / equity
0.78×
Current ratio
1.05×
Quick ratio
0.92×
Cash ratio
0.05×

Cash flow

Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$9.93M

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for COSM, quarterly periods
Line itemQ2 FY2026 Jun 30, 2026Q1 FY2026 Mar 31, 2026Q4 FY2025 Dec 31, 2025Q3 FY2025 Sep 30, 2025Q2 FY2025 Jun 30, 2025Q1 FY2025 Mar 31, 2025Q4 FY2024 Dec 31, 2024Q3 FY2024 Sep 30, 2024
Revenue$18.99M$17.93M$19.7M$17.11M$14.75M$13.71M$14.22M$12.41M
Cost of revenue$17.47M$16.55M$17.62M$14.51M$13.58M$11.66M$13.22M$11.2M
Gross profit$1.51M$1.38M$2.08M$2.6M$1.16M$2.05M$1M$1.21M
Selling, general and administrative$4.02M$3.22M$12.6M$4.03M$3.38M$2.55M$8.83M$3.14M
Research and development$68.55K$0$410.76K$18.34K$74.64K$15.63K$533.29K$0
Total operating expenses$4.44M$3.57M$13.49M$4.42M$3.81M$2.88M$9.97M$3.45M
Operating income-$2.93M-$2.18M-$11.41M-$1.82M-$2.65M-$833.15K-$8.97M-$2.24M
Interest expense-$1M-$813.58K-$1.01M-$870.6K-$551.92K-$187.11K-$319.77K-$181.43K
Income before taxes-$6.09M-$2.81M-$10.15M-$5.35M-$2.83M-$818.1K-$9.54M-$2.18M
Income taxes$0$0$0$0$0$0$0$0
Net income-$6.09M-$2.81M-$10.15M-$5.35M-$2.83M-$818.1K-$9.54M-$2.18M
Net income attributable to common shareholders-$6.09M-$2.81M-$10.15M-$5.35M-$2.83M-$818.1K-$9.54M-$8.38M
EBITDA-$2.58M-$1.84M-$10.92M-$1.44M-$2.29M-$517.31K-$8.34M-$1.94M
Basic earnings per share-$0.10-$0.06-$0.28-$0.17-$0.10-$0.03-$0.41-$0.45
Diluted earnings per share-$0.10-$0.06-$0.28-$0.17-$0.10-$0.03-$0.41-$0.45

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
Benzinga

Cosmos Health Signs LOI to Acquire Doc Pharma S.A., a European GMP Pharmaceutical Manufacturer, a Transformative Step Expected to Boost Assets, Profitability, Production Capacity, and Product Portfolio

Cosmos Health Inc. (NASDAQ: COSM) announced a non-binding letter of intent to acquire 100% of Doc Pharma S.A., a European GMP-licensed pharmaceutical manufacturer. The acquisition is expected to be immediately accretive, expanding Cosmos Health's asset base by approximately $24 million, adding $6.7 million in average annual revenue and $3.2 million in gross profit. The deal aims to deepen vertical integration, improve margins, expand production capacity, and strengthen the company's R&D capabilities. The transaction is subject to independent director review, fairness opinion, and shareholder approval.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily
Execution dateSplit ratioEvent type
Nov 13, 20261-for-20reverse split
Dec 16, 20221-for-25reverse split
Nov 21, 20171-for-10reverse split